Efficacy of Sitagliptin and Glibenclamide on the Glucose Variability in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431-355)
Clinical trial NCT02318693 · COMPLETED
Trial details
- NCT number
- NCT02318693
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-04
- Primary completion
- 2015-12-15
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.